Book icon with persian name of Pubnito
  • Magasin
  • Bibliothèque
  • Votre panier


    Articles au total:0

    Voir le panier

    Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

    Frontiers in Clinical Drug Research - Anti-Cancer Agents: Volume 8

    Atta-ur-Rahman

    "Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics: - Key data management elements in clinical trials for oncological therapeutics - Prospects for therapeutic targeting of microRNAs in brain tumors - Breast cancer vaccines: current status and future approach - Desmocollin-3 and cancer - MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53 - Towards targeted therapy: anticancer agents targeting cell organelle mitochondria - Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials" "Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The eighth volume of the book features reviews on these topics: - Key data management elements in clinical trials for oncological therapeutics - Prospects for therapeutic targeting of microRNAs in brain tumors - Breast cancer vaccines: current status and future approach - Desmocollin-3 and cancer - MDM2-p53 antagonists under clinical evaluation: a promising cancer targeted therapy for cancer patients harbouring wild-type tp53 - Towards targeted therapy: anticancer agents targeting cell organelle mitochondria - Anticancer therapeutic strategies in gliomas: chemotherapy, immunotherapy, and molecularly targeted therapy in adults Audience: Pharmaceutical Scientists, Medicinal Chemists, Clinical Oncologists, Researchers in Pre-clinical studies and clinical trials"

    forme de livre

    licence de livre

    $ 79.00

    Commentaires

    Aperçu de la notation

    Sélectionnez une ligne ci-dessous pour filtrer les avis.

    0

    0

    0

    0

    0

    0

    Global

    Notes moyennes des clients

    Critique de ce livre

    Partagez vos réflexions avec d'autres lecteurs

    Le plus populaire

    description_of_book

    "Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for de

    Informations supplémentaires

    Fournisseur

    Date de publication

    2021 Dec 03

    Auteurs-
    Atta-ur-Rahman

    ISBN

    9781681089317

    À propos des auteurs

    Atta-ur-Rahman
    Atta-ur-Rahman
    Atta-ur-Rahman

    Table des matières

    logo

    Français

    Propulsé par PUBNiTO | © 2024 Notion Wave Inc.